通用名称

piperacillin/tazobactam

儿科标签批准日期

2020/5/26 0:00:00

特定指示/秒

Nosocomial pneumonia to include patients from 2 months to 17 years

标签更改摘要

- Use in pediatric patients 2 months of age and older with nosocomial pneumonia is supported by evidence from well-controlled studies in adults with nosocomial pneumonia, a simulation study performed with a population pharmacokinetic model, and a retrospective, cohort study of pediatric patients with nosocomial pneumonia in which 140 pediatric patients were treated with Zosyn and 267 patients treated with comparators including ticarcillin-clavulanate, carbapenems, ceftazidime, cefepime, or ciprofloxacin. - Safety and effectiveness have not been established in pediatric patients less than 2 months of age. - Information on dosing, adverse reactions and clinical trial. - Postmarketing study.

治疗类别

Antibacterials

立法类型

PREA Only

产品说明书链接